Everest Medical (01952) has received a boost of 860,000 shares from its major shareholder Fu Weizeng.

12:18 30/03/2026

Genting Hong Kong (01952) announced that the Board of Directors of the Company was informed by non-executive director and Honorary Chairman of the Board, as well as the major shareholder of the Company, Mr. Fu Wei, that on March 27, 2026, Mr. Fu Wei purchased 860,000 shares of the Company's common stock through his controlled company, with a total price of approximately HK$32.7 million, at an average price of approximately HK$38.12 per share.

Everest MED (01952) issued an announcement that the Board of Directors of the company was informed by Mr. Fu We, a non-executive director, honorary chairman of the Board, and the major shareholder of the company, that on March 27, 2026, Mr. Fu We purchased 860,000 shares of the company's common stock through his controlled company in the market. The total cost was approximately 32.7 million Hong Kong dollars, with an average price of approximately HK$38.12 per share.

HK Stock Market Move | Gambling stocks fell again, Morgan Stanley expects gambling revenue to slow starting in May, and EBITDA growth will be negative in the second and third quarters.

Citigroup: Raises CITIC (00267) target price to 13.4 Hong Kong dollars, slightly exceeding last year's performance expectations.

Caitong: Healthy sugar substitutes are growing rapidly, giving the prospects for allulose a wide future.

HK Stock Market Move | Gambling stocks fell again, Morgan Stanley expects gambling revenue to slow starting in May, and EBITDA growth will be negative in the second and third quarters.

Citigroup: Raises CITIC (00267) target price to 13.4 Hong Kong dollars, slightly exceeding last year's performance expectations.

Caitong: Healthy sugar substitutes are growing rapidly, giving the prospects for allulose a wide future.